2. Search Result
Search Result
Results for "

coronary vasodilator

" in MedChemExpress (MCE) Product Catalog:

33

Inhibitors & Agonists

2

Peptides

2

Natural
Products

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-B0203A
    Nebivolol hydrochloride
    3 Publications Verification

    R 065824 hydrochloride

    		 Adrenergic Receptor Cardiovascular Disease Endocrinology Cancer
    Nebivolol (R 065824) hydrochloride is an orally active beta receptor blocker and has the high beta(1)-receptor affinity.Nebivolol hydrochloride has direct vasodilator properties and adrenergic blocking characteristics. Nebivolol hydrochloride can be used for the research of kinds of diseases such as hypertension, coronary artery disease, congestive heart failure and ischemic heart disease .
    Nebivolol hydrochloride
  • HY-B0203
    Nebivolol
    3 Publications Verification

    R 065824

    		 Adrenergic Receptor Cardiovascular Disease Endocrinology Cancer
    Nebivolol (R 065824) is an orally active beta receptor blocker and has the high beta(1)-receptor affinity. Nebivolol has direct vasodilator properties and adrenergic blocking characteristics. Nebivolol can be used for the research of kinds of diseases such as hypertension, coronary artery disease, congestive heart failure and ischemic heart disease .
    Nebivolol
  • HY-A0168
    Regadenoson
    3 Publications Verification

    CVT-3146

    		 Adenosine Receptor Cardiovascular Disease Cancer
    Regadenoson (CVT-3146) is a selective A2A adenosine receptor agonist and vasodilator that increases coronary blood flow, can be used in study of myocardial perfusion imaging. Regadenoson also increases the permeability of the blood-brain barrier (BBB) in rodents, can be used to study increased delivery of agents to the human CNS .
    Regadenoson
  • HY-B1394
    Khellin
    2 Publications Verification

    		 EGFR Cardiovascular Disease Cancer
    Khellin is a furochromone that can be isolated from Ammi visnuga L.. Khellin is an EGFR inhibitor with an IC50 of 0.15 µM. Khelline has anti-proliferative activity in vitro. Khellin has antispasmodic and coronary vasodilator effects .
    Khellin
  • HY-P1913A
    Calcitonin Gene Related Peptide II (rat) TFA
    1 Publications Verification

    CGRP II (rat) TFA

    		 CGRP Receptor Cardiovascular Disease
    Calcitonin Gene Related Peptide II rat TFA, a CGRP receptor activator, is a potent and long-lasting vasodilator. Calcitonin Gene Related Peptide II rat TFA can be used in the research of cardiovascular diseases .
    Calcitonin Gene Related Peptide II (rat) TFA
  • HY-108300
    Oxyfedrine hydrochloride

    		Adrenergic Receptor Cardiovascular Disease
    Oxyfedrine hydrochloride, a vasodilator, is an orally active β-adrenoreceptor agonist. Oxyfedrine decreases the tonicity of coronary vessels. Oxyfedrine hydrochloride can be used in the research of cardiovascular disease .
    Oxyfedrine hydrochloride
  • HY-106450
    Binodenoson

    MRE-0470; WRC 0470

    		 Adenosine Receptor Cardiovascular Disease
    Binodenoson (MRE-0470) is a potent and selective A2A adenosine receptor agonist (KD=270 nM). Binodenoson is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging .
    Binodenoson
  • HY-B0930
    Efloxate

    Angorlisin

    		 Bacterial Infection Cardiovascular Disease
    Efloxate (Angorlisin) is a vasodilator used in the research of chronic coronary insufficiency and angina pectoris. Efloxate binds to Staphylococcus aureus sortase A .
    Efloxate
  • HY-112070
    Oxyfedrine

    		Adrenergic Receptor Cardiovascular Disease
    Oxyfedrine, a vasodilator, is an orally active β-adrenoreceptor agonist. Oxyfedrine decreases the tonicity of coronary vessels. Oxyfedrine can be used in the research of cardiovascular disease .
    Oxyfedrine
  • HY-U00172
    Ipramidil

    C80-1324

    		 Guanylate Cyclase Cardiovascular Disease
    Ipramidil (C80-1324) is a vasodilator with significant active dilation of coronary circulation in isolated hearts. Ipramidil can cause an increase in NO release and stimulate guanylate cyclase activity.
    Ipramidil
  • HY-106523
    Nipradolol

    KT 210; K 351; Hypadil

    		 Adrenergic Receptor Cardiovascular Disease
    Nipradolol (KT-210; K-351) is a potent blocker of alpha-1-adrenergic receptors. Nipradolol inhibits the increase of intraocular pressure (IOP) in an albino rabbit model induced by Phenylephrine (HY-B0769). Nipradolo suppresses the noradrenaline (NA)-induced muscles contraction, also exhibits vasodilator activity on the dog coronary artery .
    Nipradolol
  • HY-P1913
    Calcitonin Gene Related Peptide II (rat)

    CGRP II (rat)

    		 CGRP Receptor Cardiovascular Disease
    Calcitonin Gene Related Peptide II rat, a CGRP receptor activator, is a potent and long-lasting vasodilator. Calcitonin Gene Related Peptide II rat can be used in the research of cardiovascular diseases .
    Calcitonin Gene Related Peptide II (rat)
  • HY-108982
    UK 55444

    		Calcium Channel Cardiovascular Disease
    UK 55444 is a calcium antagonist. UK 55444 has coronary vasodilator activity .
    UK 55444
  • HY-117618
    KF-14124

    		Drug Derivative Cardiovascular Disease
    KF-14124, an orally active organic nitrate, a long-acting vasodilator with highly selective venous dilating action. KF-14124 is used in the study for angina pectoris. KF-14124 shows good oral inhibition of lysine-vasopressin induced coronary vasospasm with a potency .
    KF-14124
  • HY-105651A
    Butalamine hydrochloride

    		Cholinesterase (ChE) Cardiovascular Disease
    Butalamine (hydrochloride) is a peripheral vasodilator with local anesthetic effects. :Butalamine (hydrochloride) can produce in animals coronary vasodilation, local anaesthesia, analgesia and a papaverine like action in duodenal preparations. Butalamine (hydrochloride) causes a slowing in rate of spontaneous activity, a decrease in amplitude and a reduction in isolated human smooth muscle .
    Butalamine hydrochloride
  • HY-105651AR
    Butalamine hydrochloride (Standard)

    		Cholinesterase (ChE) Reference Standards Cardiovascular Disease
    Butalamine (hydrochloride) (Standard) is the analytical standard of Butalamine (hydrochloride). This product is intended for research and analytical applications. Butalamine (hydrochloride) is a peripheral vasodilator with local anesthetic effects. :Butalamine (hydrochloride) can produce in animals coronary vasodilation, local anaesthesia, analgesia and a papaverine like action in duodenal preparations. Butalamine (hydrochloride) causes a slowing in rate of spontaneous activity, a decrease in amplitude and a reduction in isolated human smooth muscle .
    Butalamine hydrochloride (Standard)
  • HY-128551
    Droprenilamine

    		Drug Intermediate Cardiovascular Disease
    Droprenilamine is a coronary vasodilator .
    Droprenilamine
  • HY-176333
    Nebivolol O-β-D-glucuronide

    		Adrenergic Receptor Cardiovascular Disease Endocrinology
    Nebivolol O-β-D-glucuronide is a derivative of Nebivolol (HY-B0203). Nebivolol is an orally active beta receptor blocker and has the high beta(1)-receptor affinity. Nebivolol has direct vasodilator properties and adrenergic blocking characteristics. Nebivolol can be used for the research of kinds of diseases such as hypertension, coronary artery disease, congestive heart failure and ischemic heart disease .
    Nebivolol O-β-D-glucuronide
  • HY-W714710
    Teopranitol

    KC-046

    		 Prostaglandin Receptor Cardiovascular Disease
    Teopranitol (KC-046), a coronary vasodilator with a rather selective venous dilatation, is used for the study of the acute myocardial ischemia .
    Teopranitol
  • HY-165067
    14,15-EE-8(Z)-E

    14,15-Epoxyeicosa-8(Z)-enoic acid

    		 Drug Derivative Cardiovascular Disease
    14,15-EE-8(Z)-E (14,15-Epoxyeicosa-8(Z)-enoic acid) has potent vasodilator agonist activity in bovine coronary arteries. 14,15-EE-8(Z)-E is a 14,15-EET (HY-113489) analog. EETs represent important mediators of coronary vascular tone .
    14,15-EE-8(Z)-E
  • HY-B1394R
    Khellin (Standard)

    		Reference Standards EGFR Cardiovascular Disease Cancer
    Khellin (Standard) is the analytical standard of Khellin. This product is intended for research and analytical applications. Khellin is a furochromone that can be isolated from Ammi visnuga L.. Khellin is an EGFR inhibitor with an IC50 of 0.15 μM. Khelline has anti-proliferative activity in vitro. Khellin has antispasmodic and coronary vasodilator effects .
    Khellin (Standard)
  • HY-A0168A
    Regadenoson hydrate

    CVT-3146 hydrate

    		 Adenosine Receptor Cardiovascular Disease
    Regadenoson hydrate (NSC 169186) is a selective A2A adenosine receptor agonist and vasodilator that increases coronary blood flow, can be used in study of myocardial perfusion imaging. Regadenoson hydrate also increases the permeability of the blood-brain barrier (BBB) in rodents, can be used to study increased delivery of agents to the human CNS .
    Regadenoson hydrate
  • HY-126182
    Deacetyldiltiazem

    		Endogenous Metabolite Cardiovascular Disease
    Deacetyldiltiazem is a metabolite with coronary vasodilator activity. Deacetyldiltiazem is present in the plasma of individuals taking Diltiazem. The deacetylase activity of deacetyldiltiazem is mainly catalyzed by the rat Ces2a enzyme. In vitro experiments of deacetyldiltiazem showed that its Km value was similar to that of rat liver microsomes, showing efficient deacetylase activity. The study of deacetyldiltiazem helps to understand the differences in the metabolic kinetics of compounds between different species .
    Deacetyldiltiazem
  • HY-105646A
    Chromonar hydrochloride

    Carbocromen hydrochloride

    		 Biochemical Assay Reagents Cardiovascular Disease
    Chromonar hydrochloride (Carbocromen hydrochloride) is an orally active, selective long-acting coronary vasodilator. Chromonar hydrochloride increases coronary blood flow. Chromonar hydrochloride is used for the research of angina pectoris .
    Chromonar hydrochloride
  • HY-A0168R
    Regadenoson (Standard)

    CVT-3146 (Standard)

    		 Reference Standards Adenosine Receptor Cardiovascular Disease
    Regadenoson (Standard) is the analytical standard of Regadenoson. This product is intended for research and analytical applications. Regadenoson (CVT-3146) is a selective A2A adenosine receptor agonist and vasodilator that increases coronary blood flow, can be used in study of myocardial perfusion imaging. Regadenoson also increases the permeability of the blood-brain barrier (BBB) in rodents, can be used to study increased delivery of agents to the human CNS .
    Regadenoson (Standard)
  • HY-B0203AR
    Nebivolol hydrochloride (Standard)

    R 065824 hydrochloride (Standard)

    		 Reference Standards Adrenergic Receptor Cardiovascular Disease Endocrinology
    Nebivolol (hydrochloride) (Standard) is the analytical standard of Nebivolol (hydrochloride). This product is intended for research and analytical applications. Nebivolol (R 065824) hydrochloride is an orally active beta receptor blocker and has the high beta(1)-receptor affinity.Nebivolol hydrochloride has direct vasodilator properties and adrenergic blocking characteristics. Nebivolol hydrochloride can be used for the research of kinds of diseases such as hypertension, coronary artery disease, congestive heart failure and ischemic heart disease .
    Nebivolol hydrochloride (Standard)
  • HY-106458
    Niludipine

    Bay a 7168

    		 Calcium Channel Cardiovascular Disease
    Niludipine (Bay a 7168) is an orally active calcium channel blocker and vasodilator with antihypertensive effects. Niludipine can improve early fatal ventricular arrhythmias induced by acute myocardial ischemia in rats. Niludipine can reduce left ventricular systolic and diastolic loads during pacing-induced angina pectoris. Niludipine can be used in the research of cardiovascular diseases such as coronary heart disease and myocardial ischemia .
    Niludipine
  • HY-106804
    MS 857

    		Phosphodiesterase (PDE) Cardiovascular Disease
    MS 857 is an orally active nonglycoside and nonsympathomimetic cardiotonic agent. MS 857 exhibits cardiac and coronary vasodilator effect .
    MS 857
  • HY-108291
    Propatyl nitrate

    		Others Cardiovascular Disease
    Propatyl nitrate is a coronary vasodilator. Propatyl nitrate is also a nitric oxide donor. Propatyl nitrate can be used in research on cardiovascular and cerebrovascular diseases such as acute angina attacks .
    Propatyl nitrate
  • HY-118991
    KT-1

    		Adenosine Receptor Cardiovascular Disease
    KT-1 is a vasodilator. KT 1 can decrease aortic pressure, renal blood flow, left ventricular enddiastolic pressure and resistances of total peripheral, vertebral, coronary and renal vasculatures and increase aortic blood flow, vertebral blood flow, coronary blood flow, peak positive left ventricular dP/dt and heart rate in anesthetized open-chest dogs. KT-1 can be used for the research of cardiovascular disease .
    KT-1
  • HY-108300R
    Oxyfedrine hydrochloride (Standard)

    		Reference Standards Adrenergic Receptor Cardiovascular Disease
    Oxyfedrine hydrochloride (Standard) is the analytical standard of Oxyfedrine (hydrochloride) (HY-108300). This product is intended for research and analytical applications. Oxyfedrine hydrochloride, a vasodilator, is an orally active β-adrenoreceptor agonist. Oxyfedrine decreases the tonicity of coronary vessels. Oxyfedrine hydrochloride can be used in the research of cardiovascular disease .
    Oxyfedrine hydrochloride (Standard)
  • HY-106450R
    Binodenoson (Standard)

    MRE-0470 (Standard); WRC 0470 (Standard)

    		 Reference Standards Adenosine Receptor Cardiovascular Disease
    Binodenoson (Standard) is the analytical standard of Binodenoson (HY-106450). This product is intended for research and analytical applications. Binodenoson (MRE-0470) is a potent and selective A2A adenosine receptor agonist (KD=270 nM). Binodenoson is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging .
    Binodenoson (Standard)
  • HY-165005A
    (±)14(15)-EET Methyl ester

    		Drug Derivative Cardiovascular Disease
    (±) 14 (15)-EET Methyl ester (Compound 14,15-EET-Me) is a 14,15-EET (HY-113489) analog and vasodilatory agonist. (±) 14 (15)-EET Methyl ester induces relaxation of precontracted bovine coronary arteries .
    (±)14(15)-EET Methyl ester

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: